T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence
Cancers · 06.09.2023 · 15 (18) · 4437
DOI: 10.3390/cancers15184437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 06.09.2023. Verfasst von Savannah R Duenweg und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIH/NCI.
Abstract (Originalsprache)
Prostate cancer (PCa) is the most diagnosed non-cutaneous cancer in men. Despite therapies such as radical prostatectomy, which is considered curative, distant metastases may form, resulting in biochemical recurrence (BCR). This study used radiomic features calculated from multi-parametric magnetic resonance imaging (MP-MRI) to evaluate their ability to predict BCR and PCa presence. Data from a total of 279 patients, of which 46 experienced BCR, undergoing MP-MRI prior to surgery were assessed for this study. After surgery, the prostate was sectioned using patient-specific 3D-printed slicing jigs modeled using the T2-weighted imaging (T2WI). Sectioned tissue was stained, digitized, and annotated by a GU-fellowship trained pathologist for cancer presence. Digitized slides and annotations were co-registered to the T2WI and radiomic features were calculated across the whole prostate and cancerous lesions. A tree regression model was fitted to assess the ability of radiomic features to predict BCR, and a tree classification model was fitted with the same radiomic features to classify regions of cancer. We found that 10 radiomic features predicted eventual BCR with an AUC of 0.97 and classified cancer at an accuracy of 89.9%. This study showcases the application of a radiomic feature-based tool to screen for the presence of prostate cancer and assess patient prognosis, as determined by biochemical recurrence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226, USA.
- Department of Radiology, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226, USA.
- Department of Electrical Engineering and Computer Science, Milwaukee School of Engineering, 1025 N Broadway, Milwaukee, WI 53202, USA.
- Department of Pathology, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226, USA.
- Department of Urology, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226, USA.
- Department of Biomedical Engineering, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226, USA.
ORCID-Profile: Savannah R Duenweg, Peter S LaViolette
Förderung
- NCI NIH HHS
- NIH HHS
- NIH/NCI
- State of Wisconsin Tax Check-Off Program for Prostate Cancer Research
Zitieren
APA
Duenweg, S. R., Bobholz, S. A., Barrett, M. J., Lowman, A. K., Winiarz, A., Nath, B., Stebbins, M., Bukowy, J., Iczkowski, K. A., Jacobsohn, K. M., Vincent-Sheldon, S., & LaViolette, P. S. (2023). T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence. Cancers, 15(18), 4437. https://doi.org/10.3390/cancers15184437
Vancouver
Duenweg SR, Bobholz SA, Barrett MJ, Lowman AK, Winiarz A, Nath B, et al. T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence. Cancers. 2023;15(18):4437. doi:10.3390/cancers15184437
BibTeX
@article{Duenweg2023,
author = {Duenweg, Savannah R and Bobholz, Samuel A and Barrett, Michael J and Lowman, Allison K and Winiarz, Aleksandra and Nath, Biprojit and Stebbins, Margaret and Bukowy, John and Iczkowski, Kenneth A and Jacobsohn, Kenneth M and Vincent-Sheldon, Stephanie and LaViolette, Peter S},
title = {T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence},
journal = {Cancers},
year = {2023},
volume = {15},
number = {18},
pages = {4437},
doi = {10.3390/cancers15184437}
}
EUVIMED